http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RS-20050051-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c8c371c715afd0fe86668bc56b74d2b6 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-36 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-36 |
| filingDate | 2003-07-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a6c5d6941bda1ee7231f09f8907cf844 |
| publicationDate | 2007-06-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RS-20050051-A |
| titleOfInvention | PHARMACEUTICAL ACTIVE INGREDIENTS OF MEDICINAL PRODUCTS AND MEDICINAL PRODUCTS CONTAINING THROMBINE OR WITH THE POSSIBILITY OF FORMING THROMBIN |
| abstract | The present invention relates to a preparation of a pharmaceutically active substance for the preparation of a medicament which contains thrombin or is capable of generating thrombin. The composition of the present invention comprises: (A) prothrombin (coagulation factor II) derived from plasma or genetic engineering, (B) coagulation factors V, VIII, IX and X derived from plasma or genetically engineered, which may, at least in part, be present in their activated form, and plasma coagulation factor XIa obtained by genetic engineering, and (C) phospholipids that promote coagulation, prion-safe coagulation, these phospholipids may optionally be contained in liposomes. |
| priorityDate | 2002-07-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 31.